<b><i>Aim:</i></b> To describe the risk factors and molecular epidemiology of nosocomial bloodstream infections caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae in a tertiary care hospital. <b><i>Methods:</i></b> Patients with enterobacteria-positive blood cultures were included. ESBL expression in the isolates was detected using the combination disk method. Antimicrobial susceptibility testing was performed using the disk diffusion method. <i>bla</i><sub>SHV</sub>, <i>bla</i><sub>TEM</sub>, and <i>bla</i><sub>CTX-M</sub> genes were identified in the isolated strains by PCR and sequencing. <i>Klebsiella pneumoniae</i> isolates were genotyped by PFGE. <b><i>Results:</i></b> Of the 90 isolates recovered, half were found to express ESBLs. Twenty-eight (62%) of these isolates were <i>K. pneumoniae,</i> 8 (18%) were <i>Escherichia coli,</i> 6 (13%) were <i>Enterobacter cloacae,</i> and 3 (7%) were <i>Serratia marcescens</i>. Multivariate logistic regression analysis showed that the only independent risk factor associated with infection by ESBL-producing strains was use of broad-spectrum cephalosporins. None of the isolates was resistant to imipenem. The<i> bla</i><sub>SHV5</sub> gene was detected in 84% of isolates, followed by <i>bla</i><sub>CTX-M15</sub> (27%), <i>bla</i><sub>SHV2</sub> (9%), and <i>bla</i><sub>SHV12</sub> (7%). PFGE identified six clones among the 28 ESBL-producing <i>K. pneumoniae </i>isolates. <b><i>Conclusions:</i></b> ESBL-producing <i>K. pneumoniae</i> clones were detected throughout the hospital. Use of broad-spectrum cephalosporins is the most important risk factor associated with the proliferation of ESBL-producing strains.